How metabolic regulation affects immune cells in pancreatic cancer.
Metabolic regulation of immunosuppressive myeloid cells in the tumor microenvironment of pancreatic cancer.
This study is looking at how changes in metabolism affect immune cells that can make it harder for the body to fight pancreatic cancer, with the hope of finding new ways to improve treatments for patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-11064902 on NIH RePORTER |
What this research studies
This research investigates the role of metabolic regulation in immune cells within the tumor microenvironment of pancreatic cancer. It focuses on understanding how certain immune cells, which suppress the body's ability to fight cancer, can be influenced by metabolic changes. By studying the effects of specific genes and metabolites on these immune cells, the research aims to identify new therapeutic strategies that could enhance the effectiveness of existing treatments. Patients may benefit from insights that could lead to improved immunotherapy options for pancreatic cancer.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with pancreatic ductal adenocarcinoma who are seeking new treatment options.
Not a fit: Patients with other types of cancer or those who do not have pancreatic cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective immunotherapy treatments for pancreatic cancer patients.
How similar studies have performed: Previous research has shown promising results in enhancing immunotherapy effectiveness in other cancers, suggesting potential for success in this area as well.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Zhang, Yaqing — University of Michigan at Ann Arbor
- Study coordinator: Zhang, Yaqing
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.